BioCentury
ARTICLE | Company News

Agenus, 4-Antibody deal

February 17, 2014 8:00 AM UTC

Agenus completed the acquisition of antibody company 4-Antibody for 3.3 million shares, which is valued at about $10.1 million based on Agenus' closing price of $3.03 on Feb. 12, before the close of t...